Federal Register. Confidentiality of Substance Use Disorder Patient Records. Start Preamble. Start Printed Page 6. AGENCY Substance Abuse and Mental Health Services Administration, HHS. ACTION Final rule. SUMMARY The Department of Health and Human Services HHS is issuing this final rule to update and modernize the Confidentiality of Alcohol and Drug Abuse Patient Records regulations and facilitate information exchange within new health care models while addressing the legitimate privacy concerns of patients seeking treatment for a substance use disorder. These modifications also help clarify the regulations and reduce unnecessary burden. DATES Effective date This final rule is effective February 1. Start Further Info. JaAPeQphaLc/Tdj4xuda9AI/AAAAAAAACRE/b2sI6gTgZrI/s600/Firefox-5+new.jpg' alt='Photo Calendar Maker 2.51 Software Serial' title='Photo Calendar Maker 2.51 Software Serial' />FOR FURTHER INFORMATION CONTACT Danielle Tarino, Telephone number 2. Email address Privacy. Regulationssamhsa. Startups news from the, including the latest news, articles, quotes, blog posts, photos, video and more. ALDI is adding another Smartphone to their stock. Accompanying the Bauhn Smartphone that graced ALDI Shelves is the Medion 4 Dual Sim for 149. What do you thi. End Further Info. End Preamble. Start Supplemental Information. SUPPLEMENTARY INFORMATION Preamble Table of Contents. I. Executive Summary. A. Purpose of the Regulatory Action. Photo Calendar Maker 2.51 Software Serial' title='Photo Calendar Maker 2.51 Software Serial' />B. Summary of the Major Provisions. C. Summary of Impacts. II. Background. A. Significant Technology Changes. B. Statutory and Rulemaking History. III. Overview of the Final Rule. IV. Effective Date. V. Discussion of Public Comments and Final Modifications to 4. CFR part 2. A. General Comments on the Proposed Rule. General Feedback on the Proposed Rulea. General Support for the Proposed Ruleb. General Opposition to the Proposed Rule. The Proposed Rule Did Not Go Far Enough To Facilitate Information Exchange. Final Rule Should Balance Patient Protections With Enhanced Information Exchange. Part 2 Should Align With the Health Insurance Portability and Accountability Act. B. Statutory Authority  2. C. Reports of Violations   2. D. Definitions   2. New Definitionsa. Part 2 Programb. Part 2 Program Directorc. Substance Use Disorderd. Treating Provider Relationshipe. Withdrawal Management. Existing Definitionsa. Central Registryb. Disclose or Disclosurec. Maintenance Treatmentd. Member Programe. Patientf. Patient Identifying Informationg. Personh. Programi. Qualified Service Organizationj. Recordsk. Treatment. Terminology Changes. Other Comments on Definitions. E. Applicability   2. F. Confidentiality Restrictions and Safeguards   2. Delayed Implementation of List of Disclosures Provision. Responsibilities Under the List of Disclosures Process. Technological Challenges and Burden of the List of Disclosures Provision. Recommendations to Further Protect Patient Privacy. Other Comments and Recommendations on the List of Disclosures Provision. G. Security for Records   2. H. Disposition of Records by Discontinued Programs   2. I. Notice to Patients of Federal Confidentiality Requirements   2. J. Consent Requirements   2. General Comments on Consent Requirementsa. Generalb. Consent Form Validity Periodc. Technical Challenges to Proposed Consent Requirementsd. Requests for Exemptions and Exceptionse. Commenter Recommendations. To Whoma. Generalb. Determination of Treating Provider Relationshipc. Requests for Clarificationd. Commenter Recommendationse. Proposed Alternative Approach for To Whom Section. Amount and Kinda. Generalb. Impact of the Amount and Kind Requirement on Providers and Patientsc. Required Substance Use Disorder Information on Consent Formsd. Requests for Clarification. From Whom. 5. New Requirements. K. Prohibition on Re Disclosure   2. General. 2. Impact of Re Disclosure Prohibition on Patient Privacy and Patient Choice. Disclosure of Information that May Indicate a Substance Use Disorder. Technical Challenges in Preventing Unauthorized Re Disclosure. Requests for Clarification of the Re Disclosure Prohibition. Recommendations to Improve the Prohibition on Re Disclosure. L. Disclosures to Prevent Multiple Enrollments   2. M. Medical Emergencies   2. General. 2. Definition of Bona Fide Medical Emergency3. Documentation of Medical Emergency. Other Comments on Medical Emergency. N. Research   2. General. Suggestions for Improvement of the Research Provisions. HIPAA and HHS Common Rule Requirements. Data Linkages. 5. Multi Payer Claims Database. O. Audit and Evaluation   2. P. Other Public Comments on the Proposed Rule. Requests to Extend the Public Comment Period. Rulemaking Process. Implementation Timeline and Other Barriers to Implementation. Educational Opportunities. Increased Enforcement. Other Miscellaneous Comments on the Proposed Rule. VI. Rulemaking Analyses. A. Paperwork Reduction Act. B. Regulatory Impact Analysis. C. Regulatory Flexibility Act. D. Unfunded Mandates Reform Act. E. Federalism Executive Order 1. Acronyms. ACO Accountable Care Organization. ABAM American Board of Addiction Medicine. ADAMHA Alcohol, Drug Abuse and Mental Health Administration. APCD All Payer Claims Database. ARRA American Recovery and Reinvestment Act of 2. Pub. L. 1. 11 5ASAM American Society of Addiction Medicine. ATR Access to Recovery. C CDA Consolidated Clinical Document Architecture. CCD Continuity of Care Document. CCLF Claim and Claim Line Feed. CCO Coordinated Care Organization. CFR Code of Federal Regulations. CHIP Childrens Health Insurance Program. CMS Centers for Medicare Medicaid Services. CPCMH Certified Patient Centered Medical Home. DS4. P Data Segmentation for Privacy. EHR Electronic Health Record. EQRO External Quality Review Organization. FAQ Frequently Asked Question. FAX Facsimile. FDA Food and Drug Administration. FR Federal Register. HHS Department of Health and Human Services. HIE Health Information Exchange. HIO Health Information Organization. HIPAA Health Insurance Portability and Accountability Act of 1. Pub. L. 1. 04 1. HITECH Health Information Technology for Economic and Clinical Health Act of 2. Pub. L. 1. 11 5, title XIII of division A and title IV of division BHITPC Health Information Technology Privacy Committee. IG Implementation Guide. IRB Institutional Review Board. IT Information Technology. Start Printed Page 6. MCO Managed Care Organization. MPCD Multi Payer Claims Database. NCQA National Committee for Quality Assurance. NPRM Notice of Proposed Rulemaking. N SSATS National Survey of Substance Abuse Treatment Services. OHRP Office for Human Research Protections. OMB Office of Management and Budget. ONC Office of the National Coordinator for Health Information Technology. PDMP Prescription Drug Monitoring Program. PPS Performing Provider System. QE Qualified Entity. QSO Qualified Service Organization. QSOA Qualified Service Organization Agreement. RFA Regulatory Flexibility Act. RHIO Regional Health Information Organization. SAMHSA Substance Abuse and Mental Health Services Administration. Download Grab And Smith Plastic Surgery Free. SBIRT Screening, Brief Intervention, and Referrals for Treatment. S I Standards and Interoperability. TEDS Treatment Episode Data Set. U. S. C.  United States Code. USAO United States Attorneys Office. VA Department of Veterans Affairs. I. Executive Summary. A. Purpose of the Regulatory Action. The laws and regulations governing the confidentiality of substance use disorder records were written out of great concern about the potential use of substance use disorder information against individuals, causing individuals with substance use disorders not to seek needed treatment. The disclosure of records of individuals with substance use disorders has the potential to lead to a host of negative consequences, including Loss of employment, loss of housing, loss of child custody, discrimination by medical professionals and insurers, arrest, prosecution, and incarceration. The purpose of the regulations at title 4.